The Curbsiders Internal Medicine Podcast cover image

#373 Recap Extravaganza 2022

The Curbsiders Internal Medicine Podcast

00:00

Is There a New Therapy for H.Pylori?

The Chlorithromycin-based triple therapy is not recommended anymore by the guidelines or Dr. Safari. There's a Bismuth-based quadruple therapy that can be tough for patients to tolerate. Rifabudin-containing therapy, Paul, I probably won't be prescribing that without conferring with one of my gastroenterology colleagues or ID colleagues. A new agent called Vanoeprazan seems very promising and they're already using it in Asia.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app